choline receptor partial agonist vs. sustained-release bupropion and placebo for smoking cessation. JAMA 2006; 296(1):47-55. 47. Kessler RC, Berglund PA, Borges G, Castilla-Puentes RC, Glantz MD, Jaeger SA, et al. Smoking and suicidal behaviors in the Nat
Smoking is a chronic disease due to physical and psychological nicotine dependence and remains as the leading cause of preventable mortality. Availability of tobacco products and social approval has a great impact on consumption in the general population. Smoking is a paradoxical problem. Although m...
| Autor Principal: | Becerra, Nelci Astrid; Pontificia Universidad Javeriana |
|---|---|
| Otros Autores: | Cañón, Martín; Pontificia Universidad Javeriana, Vivas, José Manuel; Pontificia Universidad Javeriana |
| Formato: | info:eu-repo/semantics/article |
| Idioma: | spa |
| Publicado: |
Pontificia Universidad Javeriana
2010
|
| Materias: | |
| Acceso en línea: |
http://revistas.javeriana.edu.co/index.php/vnimedica/article/view/15980 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: |
Smoking is a chronic disease due to physical and psychological nicotine dependence and remains as the leading cause of preventable mortality. Availability of tobacco products and social approval has a great impact on consumption in the general population. Smoking is a paradoxical problem. Although multiple cost-effective therapies are available, health practitioners are barely trained or motivated to treatthese patients. Appropriate specialized centers and health coverage for its management are also lacking. Pharmacological therapy must be a part of an organized, interdisciplinary and multifactorial strategy, prescribed in an adequate stage of change. This article is a review of the pharmacological treatment for smoking cessation. |
|---|